Incidence and risk factors of hypomagnesemia in head and neck cancer patients treated with cetuximab
Background Hypomagnesemia is a common adverse event during cetuximab (Cmab) treatment. However, few reports have investigated the incidence and risk factors of hypomagnesemia in head and neck cancer patients treated with Cmab. Methods We retrospectively reviewed 131 head and neck cancer patients who...
| Những tác giả chính: | , , , , , |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | English |
| Được phát hành: |
Frontiers Media S.A.
2016-09-01
|
| Loạt: | Frontiers in Oncology |
| Những chủ đề: | |
| Truy cập trực tuyến: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00196/full |